Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Kurtoglu Metin. Officer active across 1 company, notably Cartesian Therapeutics, Inc.. Cumulatively, 6 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €39k. History available since 2 January 2024. The latest transaction was filed on 3 January 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Kurtoglu Metin is a declarant linked to Cartesian Therapeutics, Inc. on XNAS, where the listed role is Chief Technology Officer. Across 6 filings in total, the 6 sampled filings cover the period from 2024-01-04 to 2025-01-07 and show 0 in buys and 39361 in sells, with the modal transaction nature listed as option exercise.